Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF-Reference-Cited by-同舟云学术

Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF

Published:2021-11-24 Issue: Volume: Page:
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Butt Jawad H.¹²,Docherty Kieran F.¹,Jhund Pardeep S.¹,Boer Rudolf A.³,Böhm Michael⁴,Desai Akshay S.⁵,Howlett Jonathan G.⁶,Inzucchi Silvio E.⁷,Kosiborod Mikhail N.⁸,Martinez Felipe A.⁹,Nicolau Jose C.¹⁰,Petrie Mark C.¹,Ponikowski Piotr¹¹,Bengtsson Olof¹²,Langkilde Anna Maria¹²,Schou Morten¹³,Sjöstrand Mikaela¹²,Solomon Scott D.⁵,Sabatine Marc S.⁵¹⁴,McMurray John J.V.¹^ORCID,Køber Lars²

Affiliation:

1. British Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UK

2. Department of Cardiology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

3. Department of Cardiology University Medical Center and University of Groningen Groningen The Netherlands

4. Department of Internal Medicine III, Saarland University Hospital Saarland University Homburg Germany

5. Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA USA

6. Cumming School of Medicine and Libin Cardiovascular Institute University of Calgary Calgary Canada

7. Section of Endocrinology Yale School of Medicine New Haven CT USA

8. Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City; The George Institute for Global Health University of New South Wales Sydney Australia

9. Universidad Nacional de Córdoba Córdoba Argentina

10. Instituto do Coracao (InCor), Hospital das Clínicas Faculdade de Medicina Universidade de São Paulo São Paulo Brazil

11. Center for Heart Diseases University Hospital, Wroclaw Medical University Wrocław Poland

12. Late Stage Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden

13. Department of Cardiology Herlev‐Gentofte University Hospital Herlev Denmark

14. TIMI Study Group, Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2381

Reference35 articles.

1. Atrial Fibrillation Begets Heart Failure and Vice Versa

2. Atrial fibrillation in heart failure: what should we do?;Kotecha D;Eur Heart J,2015

3. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction

4. Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trial

5. Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review;Journal of Clinical Medicine;2024-09-12

2. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

3. Rapid Uptitration of Guideline-Directed Medical Therapies in Acute Heart Failure With and Without Atrial Fibrillation;JACC: Heart Failure;2024-08

4. Impact of Sodium-glucose Cotransporter 2 Inhibitor on Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure;Heart Rhythm;2024-08

5. Temporal trends in mortality, heart failure hospitalization, and stroke in heart failure patients with and without atrial fibrillation: a nationwide study from 1997 to 2018 on 152 059 patients;European Heart Journal - Quality of Care and Clinical Outcomes;2024-07-22